Correlation between clozapine use and metabolic syndrome in schizophrenic patients
DOI:
https://doi.org/10.46542/pe.2023.232.103112Keywords:
Clozapine, Metabolic syndrome, SchizophreniaAbstract
Background: Clozapine, an atypical antipsychotic agent, is effective for relapse or refractory schizophrenia that has failed to respond to other antipsychotic medications. Despite its effectiveness, clozapine has a higher risk of metabolic syndrome than other antipsychotics.
Objective: This research aimed to identify the correlation between clozapine and metabolic syndrome, such as obesity, cholesterol, and blood glucose levels, in schizophrenic patients at Ghrasia Mental Hospital, Yogyakarta, Indonesia.
Method: This is a cross-sectional research. Subjects who met the inclusion criteria were randomly sampled from outpatients between November 2021 and February 2022. The research collected medical record data (characteristic patients, medication patterns, and body mass index) and analysed blood profiles (cholesterol and glucose levels). The data were analysed descriptively and statistically.
Result: Among the 71 patients in this research, 37 (52.11%) were male and 34 (47.89%) were female, with an average age of 36-45 years. The treatment patterns of patients were as follows: 44 were taking only clozapine and 27 patients did not use clozapine. Clozapine was frequently combined with risperidone and haloperidol in this research. Bivariate analysis using Fisher's Exact test revealed no significant correlation between clozapine use, clozapine regimen (single or combined), duration of clozapine therapy (>= 5 years), and clozapine dose (high or low) with obesity, hypercholesterolemia, and hyperglycemia. Meanwhile, multivariate analysis revealed a significant correlation between gender and obesity (p < 0.05), with women having a 0.299 higher risk than men. The effects of age and duration of schizophrenia on hypercholesterolemia and hyperglycemia were insignificant.
Conclusion: There was no correlation found between clozapine use and metabolic syndrome. Gender was found to have a significant correlation with obesity in the research.
References
Agaba, D.C., Migisha, R., Namayanja, R., Katamba, G., Lugobe, H.M., Aheisibwe, H., Twesigomwe, G., & Ashaba, S. (2019). Prevalence and Associated Factors of Metabolic Syndrome among Patients with Severe Mental Illness Attending a Tertiary Hospital in Southwest Uganda. BioMed Research International, e1096201. https://doi.org/10.1155/2019/1096201
Akhfiya, M., & Syamsianah, A., Mufnaetty. (2018). Kadar Kolesterol Total Wanita Menopause Hiperkolesterolemia Sesudah Pemberian Teh Buah Tin. Journal Gizi, 7 (2). https://doi.org/10.26714/jg.7.2.2018.%25p
Andari, S. (2017). Pelayanan Sosial Panti Berbasis Agama dalam Merehabilitasi Penderita Skizofrenia (No. 2). Jurnal PKS, 16(2). Available at: https://ejournal.kemensos.go.id/index.php/jpks/article/download/1389/794
Arania, R., Triwahyuni, T., Esfandiari, F., & Nugraha, F. R. (2021). Hubungan antara Usia, Jenis Kelamin dan Tingkat Pendidikan dengan Kejadian Diabetes Mellitus di Klinik Mardi Waluyo Lampung Tengah. Jurnal Medika Malahayati, 5(3). https://doi.org/10.33024/jmm.v5i3.4200
Aronson, J.K. (Ed.). (2016). Meyler’s side effects of drugs: The international encyclopedia of adverse drug reactions and interactions (16th ed.). Elsevier. Available at: https://www.elsevier.com/books/meylers-side-effects-of-drugs/aronson/978-0-444-53717-1
Aryani, F., & Sari, O. (2015). Gambaran Pola Penggunaan Antipsikotik pada Pasien Skizofrenia di Ruang Rawat Inap Rumah Sakit Jiwa. Journal of Management and Pharmacy Practice, 6(1). https://doi.org/10.22146/jmpf.236
Brunero, S., Lamont, S., & Fairbrother, G. (2009). Prevalence and Predictors of Metabolic Syndrome Among Patients Attending an Outpatient Clozapine Clinic in Australia. Archives of Psychiatric Nursing, 23(3). https://doi.org/10.1016/j.apnu.2008.06.007
Casey, D.E. (2004). Dyslipidemia and Atypical Antipsychotic Drugs, 9. Available at: https://pubmed.ncbi.nlm.nih.gov/15600382/
Chang, H.-Y., Yeh, W.-T., Chang, Y.-H., Tsai, K.-S., & Pan, W.-H. (2002). Prevalence of Dyslipidemia and Mean Blood Lipid Values in Taiwan: Results from the Nutrition and Health Survey in Taiwan, 11. Available at: https://pubmed.ncbi.nlm.nih.gov/12817710/
Chokhawala, K., & Stevens, L. (2021). Antipsychotic Medications. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK519503/
Correll, C.U., Frederickson, A.M., Kane, J.M., & Manu, P. (2007). Does antipsychotic polypharmacy increase the risk for metabolic syndrome? Schizophrenia Research, 89(1–3). https://doi.org/10.1016/j.schres.2006.08.017
Crismon, L., & Buckley, P. (2014). Schizophrenia. In J. DiPiro, R. Talbert, & G. Yee (Eds.), Pharmacotherapy: A pathophysiologic approach (9th ed, pp. 1019–1046). McGraw Hill Medical
Dania, H., Faridah, I.N., Rahmah, K.F., Abdulah, R., Barliana, M.I., & Perwitasari, D.A. (2019). Hubungan Pemberian Terapi Antipsikotik terhadap Kejadian Efek Samping Sindrom Ekstrapiramidal pada Pasien Rawat Jalan di Salah Satu Rumah Sakit di Bantul, Yogyakarta. Indonesian Journal of Clinical Pharmacy, 8(1). https://doi.org/10.15416/ijcp.2019.8.1.19
Dinan, T.G. (2004). Stress and the genesis of diabetes mellitus in schizophrenia. The British Journal of Psychiatry, 184(S47), s72–s75. https://doi.org/10.1192/bjp.184.47.s72
DiPiro, J.T. (Ed.). (2020). Pharmacotherapy: A pathophysiologic approach (Eleventh edition). McGraw Hill Medical. Available at: https://accesspharmacy.mhmedical.com/book.aspx?bookID=2577
Gianfrancesco, F.D., Grogg, A.L., Mahmoud, R.A., Wang, R., & Nasrallah, H.A. (2002). Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: Findings from a large health plan database. The Journal of Clinical Psychiatry, 63(10), 920–930. https://doi.org/10.4088/jcp.v63n1010
Gunawan, S., & Rahmawati, R. (2021). Hubungan Usia, Jenis Kelamin dan Hipertensi dengan Kejadian Diabetes Mellitus Tipe 2 di Puskesmas Tugu Kecamatan Cimanggis Kota Depok Tahun 2019 : Arkesmas: Arsip Kesehatan Masyarakat, 6(1). https://doi.org/10.22236/arkesmas.v6i1.5829
Haidary, H.A., & Padhy, R.K. (2021). Clozapine. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK535399/
Hanief, N., & Noor, N. (2022). Gambaran Penggunaan Obat Antipsikotik Pada Pasien Skizofrenia di Rumah Sakit Jiwa Dr. Soeharto Heerdjan Periode Januari – Juni 2017. Yarsi Journal of Pharmacology, 2(1). https://doi.org/10.33476/yjp.v2i1.2195
Henderson, D.C. (2000). Clozapine, Diabetes Mellitus, Weight Gain, and Lipid Abnormalities: A Five-Year Naturalistic Study. American Journal of Psychiatry, 157(6). https://doi.org/10.1176/appi.ajp.157.6.975
Holt, R.I.G. (2019). Association Between Antipsychotic Medication Use and Diabetes. Current Diabetes Reports, 19(10), 96. https://doi.org/10.1007/s11892-019-1220-8
Hussain, Z. khidhair, & Ali, I.H. (2021). Comparative study of obesity between men and women: Review. European Journal of Molecular & Clinical Medicine, 8(2), 367–378. Available at: https://www.researchgate.net/publication/349442770_Comparative_study_of_obesity_between_men_and_women_Review
Irawan, D. (2010). Prevalensi dan Faktor Risiko Kejadian Diabetes Melitus Tipe 2 di Daerah Urban Indonesia (Analisis Data Sekunder Riskesdas 2007) [Universitas Indonesia]. https://lib.ui.ac.id
Kementerian Kesehatan. (2019). Laporan nasional Riskesdas 2018. Lembaga Penerbit Balitbangkes, Kementerian Kesehatan, Republik Indonesia, Badan Penelitian dan Pengembangan Kesehatan. http://labdata.litbang.kemkes.go.id/images/download/laporan/RKD/2018/Laporan_Nasional_RKD2018_FINAL.pdf
Koller, E., Schneider, B., Bennett, K., & Dubitsky, G. (2001). Clozapine-associated diabetes. The American Journal of Medicine, 111(9), 716–723. https://doi.org/10.1016/s0002-9343(01)01000-2
Komariah, K., & Rahayu, S. (2020). Hubungan Usia, Jenis Kelamin dan Indeks Massa Tubuh dengan Kadar Gula Darah Puasa pada Pasien Diabetes Melitus Tipe 2 di Klinik Pratama Rawat Jalan Proklamasi, Depok, Jawa Barat. Jurnal Kesehatan Kusuma Husada, 41–50. https://doi.org/10.34035/jk.v11i1.412
Krakowski, M., Czobor, P., & Citrome, L. (2009). Weight gain, metabolic parameters, and the impact of race in aggressive inpatients randomized to double-blind clozapine, olanzapine or haloperidol. Schizophrenia Research, 110(1–3), Article 1–3. https://doi.org/10.1016/j.schres.2009.02.006
Kumar, M., & Sidana, A. (2017). Clozapine-induced Acute Hypertriglyceridemia. Indian Journal of Psychological Medicine, 39(5), Article 5. https://doi.org/10.4103/0253-7176.217031
Lamberti, J.S., Olson, D., Crilly, J.F., Olivares, T., Williams, G.C., Tu, X., Tang, W., Wiener, K., Dvorin, S., & Dietz, M.B. (2006). Prevalence of the metabolic syndrome among patients receiving clozapine. The American Journal of Psychiatry, 163(7), 1273–1276. https://doi.org/10.1176/appi.ajp.163.7.1273
Liu, X., Wu, Z., Lian, J., Hu, C.-H., Huang, X.-F., & Deng, C. (2017). Time-dependent changes and potential mechanisms of glucose-lipid metabolic disorders associated with chronic clozapine or olanzapine treatment in rats. Scientific Reports, 7, 2762. https://doi.org/10.1038/s41598-017-02884-w
McNeil, S.E., Gibbons, J.R., & Cogburn, M. (2022). Risperidone. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK459313/
Mukaddas, A., Faustin, I., & Fahrul, F. (2014). Rasionalitas Penggunaan Antipsikotik pada Pasien Skizofrenia di Instalasi Rawat Inap Jiwa RSD Madani Provinsi Sulawesi Tengah Periode Januari-April 2014. Online Jurnal of Natural Science, 3(2), Article 2. Available at: https://core.ac.uk/download/pdf/291814047.pdf
Pahlawati, A., & Nugroho, P. S. (2019). Hubungan Tingkat Pendidikan dan Usia dengan Kejadian Diabetes Melitus di Wilayah Kerja Puskesmas Palaran Kota Samarinda Tahun 2019. Borneo Student Research (BSR), 1(1), Available at: https://journals.umkt.ac.id/index.php/bsr/article/view/479
Pillinger, T., McCutcheon, R.A., Vano, L., Mizuno, Y., Arumuham, A., Hindley, G., Beck, K., Natesan, S., Efthimiou, O., Cipriani, A., & Howes, O. D. (2020). Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: A systematic review and network meta-analysis. The Lancet. Psychiatry, 7(1), https://doi.org/10.1016/S2215-0366(19)30416-X
Rahman, S., & Marwaha, R. (2022). Haloperidol. In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK560892/
Sadock, B.J., & Sadock, V.A. (2007). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry, 10th ed (pp. xv, 1470). Lippincott Williams & Wilkins Publishers. Available at: https://books.google.com.ng/books/about/Kaplan_Sadock_s_Synopsis_of_Psychiatry.html?id=u-ohbTtxCeYC&redir_esc=y
Solberg, D.K., Bentsen, H., Refsum, H., & Andreassen, O.A. (2016). Lipid profiles in schizophrenia associated with clinical traits: A five year follow-up study. BMC Psychiatry, 16(1). https://doi.org/10.1186/s12888-016-1006-3
Suastika, K., Dwipayana, I.M., Saraswati, M., Kuswardhani, T., Astika, N., Putrawan, I., Matsumoto, K., Kajiwara, N., & Taniguchi, H. (2011). Relationship between age and metabolic disorders in the population of Bali. Hydrometallurgy, 2, 47–52. https://doi.org/10.1016/j.jcgg.2011.03.001
Tovey, E., Rampes, H., & Livingstone, C. (2005). Clozapine-induced type-2 diabetes mellitus: Possible mechanisms and implications for clinical practice. Journal of Psychopharmacology (Oxford, England), 19, 207–210. https://doi.org/10.1177/0269881105049043
Ujiani, S. (2015). Hubungan Antara Usia dan Jenis Kelamin dengan Kadar Kolesterol Penderita Obesitas RSUD Abdul Moeloek Provinsi Lampung. 48 Jurnal Kesehatan, 4(1). http://dx.doi.org/10.26630/jk.v6i1.24
Usman, J., Rahman, D., & Sulaiman, N. (2020). Faktor yang Berhubungan dengan Kejadian Diabetes Mellitus pada Pasien di RSUD Haji Makassar. Jurnal Komunitas Kesehatan Masyarakat, 2(1), 16–22. Available at: https://garuda.kemdikbud.go.id/documents/detail/1929658
Ventriglio, A., Baldessarini, R. J., Vitrani, G., Bonfitto, I., Cecere, A.C., Rinaldi, A., Petito, A., & Bellomo, A. (2018). Metabolic Syndrome in Psychotic Disorder Patients Treated With Oral and Long-Acting Injected Antipsychotics. Frontiers in Psychiatry, 9, 744. https://doi.org/10.3389/fpsyt.2018.00744
Wang, P.S., Glynn, R.J., Ganz, D.A., Schneeweiss, S., Levin, R., & Avorn, J. (2002). Clozapine use and risk of diabetes mellitus. Journal of Clinical Psychopharmacology, 22(3), 236–243. https://doi.org/10.1097/00004714-200206000-00002
WHO. (2022). Schizophrenia. Available at: https://www.who.int/news-room/fact-sheets/detail/schizophrenia
Yuen, J.W.Y., Kim, D.D., Procyshyn, R.M., Panenka, W.J., Honer, W.G., & Barr, A.M. (2021). A Focused Review of the Metabolic Side-Effects of Clozapine. Frontiers in Endocrinology, 12, 67. https://doi.org/10.3389/fendo.2021.609240
Yulianty, M.D., Cahaya, N., & Srikartika, V.M. (2017). Studi Penggunaan Antipsikotik dan Efek Samping pada Pasien Skizofrenia di Rumah Sakit Jiwa Sambang Lihum Kalimantan Selatan. Jurnal Sains Farmasi & Klinis, 3(2). https://doi.org/10.29208/jsfk.2017.3.2.108
